Carl June Awarded Novartis Prize in Clinical Immunotherapy
August 25, 2016
Carl H. June, MD, the Richard W. Vague Professor in Immunotherapy in the Department of Pathology and Laboratory Medicine, is one of the three recipients of the 2016 Novartis Prize for Clinical Immunotherapy for his work developing personalized cellular therapies for cancer using Chimeric Antigen Receptor T cells (CAR T cells).
The Novartis Prizes for Immunology are awarded every three years for breakthrough contributions to the fields of basic and clinical immunology. Each of the two Prize categories is endowed for CHF 100,000 and can be shared between as many as three scientists. The winners are selected by an independent jury of world-class immunologists.
Read the Department of Communications announcement.